Nonin Technology is Advanced Technology

Advanced Technology for Proven Performance

Oximetry equipment uses near-infrared spectroscopy to measure blood oxygenation levels in the brain and other tissues. Those measurements can be affected by factors such as extraneous tissue, ambient light, variations in skin pigmentation, and the presence of myelin (in the case of infants and neonates). Sensors with only one emitter are more vulnerable to errors as a result of these factors.

Dual Emitter, Dual Detector Architecture

Nonin technology uses two emitters and two detectors in each sensor, plus patented algorithms, to create light paths through surface tissue and the cerebral cortex. This minimizes interference from extraneous tissue, variations in skin pigmentation, and ambient light. The resulting measurements are proven to be the industry’s least affected by intervening tissue or surface effects.1

Dynamic Compensation™ Algorithm

Cerebral oximetry is used in critical care environments to reduce potential complications in pediatric and neonatal surgery. Premature infants, and children with congenital heart disease (CHD), are vulnerable to neurologic complications due to cerebral hypoxia-ischemia.

These patients can have a broad range of brain development and associated tissue differences. But technologies that are not designed to account for these differences can provide inaccurate readings.

Dynamic Compensation, an exclusive, patent-pending Nonin algorithm, incorporates real-time information from the tissue being examined to eliminate the impact of myelin (a light chromophore) on the signal accuracy. This Dynamic Compensation algorithm along with sensors designed specifically for neonate and infant populations, ensures accurate information clinicians can trust without adjusting settings.

Read more about Nonin’s Dynamic Compensation Algorithm